Figure 1.
Clinical impact of patients with detectable NPM1mut MRD at completion of chemotherapy. Conversion from initial state (molecular persistence) to different outcomes censored after the first event, either sustained CRMRD−, molecular failure, or morphologic relapse without preceding molecular failure. The proportion of patients in each category at specified time points are listed in the table below.

Clinical impact of patients with detectable NPM1mut MRD at completion of chemotherapy. Conversion from initial state (molecular persistence) to different outcomes censored after the first event, either sustained CRMRD−, molecular failure, or morphologic relapse without preceding molecular failure. The proportion of patients in each category at specified time points are listed in the table below.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal